Khavinson Bioregulators: The Complete Guide
Last updated: October 3, 2026
Ultra-short peptides proposed to act on gene expression rather than surface receptors (a hypothesis from Khavinson's group). Here's a breakdown of 11 of them and some example combinations.
Programme
Cataloged Here
Build your own printable peptide tracker
A personalized injection log, weekly dosing schedule and dated calendar: your compounds filled in, ready to print. Free to build and preview; $5/month to unlock printing.

Not Like Other Peptides
As general textbook background, many peptide hormones act through cell-surface receptors. Khavinson's group proposes that bioregulators work differently. It is a hypothesis, not an established mechanism.
- General textbook contrast, not a claim about any specific compound
- Bind cell surface receptors (GPCR, tyrosine kinase, etc.)
- Trigger signaling cascade inside cell
- Signal degrades; effect fades when peptide clears
- Gene-expression changes, where they occur, are downstream of receptor signaling
- Ultra-short (2–4 amino acids), proposed to pass through the cell membrane
- Proposed to enter the cell nucleus
- Hypothesized to interact with DNA promoter regions and histones
- Proposed to regulate gene expression (a hypothesis, not established)
- Examples: Epitalon (AEDG), Pinealon (EDR), Vilon (KE)
11 Khavinson Bioregulators
Khavinson's group describes each bioregulator as acting on a particular organ or tissue. That organ specificity is proposed, not established, and some entries (Epitalon: pineal gland and retina) are linked to more than one tissue. Khavinson's group has described more bioregulators than the 11 covered here; this is a selection, not a complete list.
Example Combinations
Example combinations, listed for reference only: this page does not give recommendations or protocols. Each rationale below rests on proposed, unestablished effects, and no controlled human trial cited here has tested any of these combinations.
Timing & Cycling
Bioregulators are usually discussed as short courses with breaks rather than continuous daily use. This page has not sourced specific course lengths, rest periods, or cycles per year, so none are listed on this page.
Oral Bioavailability of Ultra-Short Peptides
Most peptides are broken down by stomach acid and gut enzymes. The case for oral bioregulators rests on their very short length (a proposed mechanism, not a demonstrated one).
Most peptides taken by mouth are broken down by gut proteases before absorption, so the biological signal is largely lost in transit.
Khavinson bioregulators are ultra-short (2–4 amino acids) — and the proposal is that the di- and tripeptides could be absorbed via the intestinal di/tripeptide transporter PEPT1. Whether the tetrapeptides (Epitalon AEDG, Cortagen AEDP, Testagen KEDG) cross the gut wall intact is not established.
Oral survival and efficacy have not been demonstrated in controlled human studies. Treat the oral route as unproven.
Related Supplies
Storage and course-tracking supplies, plus background reading on aging research. Listing them is not a recommendation to use any bioregulator. See the disclaimer below.
Affiliate links support HighPeptides at no extra cost.
Self-Assessment
Who Researches Bioregulators?
This Research Is Commonly Explored By People Who...
- Are interested in Khavinson peptide bioregulators and their proposed gene expression regulation mechanisms
- Want to understand the proposed organ-specificity hypothesis for short peptides (2-4 amino acids) from Khavinson's group, a hypothesis this page notes is not established
- Are exploring longevity and anti-aging research beyond mainstream Western approaches
- Want an overview of Epitalon, Vilon, Cortagen, and the other bioregulators cataloged on this page, along with the tissue each is proposed to target
- Are curious about the intersection of peptide therapy and epigenetic regulation
This Research May Not Be Relevant If...
- You expect Western-standard randomized controlled trials: this page does not cite any for these compounds
- You're looking for acute symptom treatment: bioregulators are usually discussed as course-based, not acute, interventions
- You want widely available, pharmacy-dispensed medications: most bioregulators are specialty peptide products
Want the Complete Protocol Guide?
Dosing schedules, interaction warnings, and cycle protocols for 20+ compounds, all in one place.
Get the Guide: $19 (normally $29) →
The Peptide Buyer’s Playbook ($19)
Compound-Specific Research Pages
Related Resources
Research-Grade Peptides
Research peptides are not FDA-approved for human use. Review each product's certificate of analysis before buying.
Browse Swiss Chems →Affiliate links support HighPeptides at no extra cost.
This page is for educational and informational purposes only. It is not medical advice, and nothing here should be interpreted as a recommendation to use any bioregulator peptide. None of the Khavinson bioregulators cataloged on this page are approved by the FDA or EMA for human use. They are research compounds. Always consult a qualified healthcare provider before making any health decisions. HighPeptides does not sell peptides. This page contains affiliate links to vendors and supplies; see the affiliate disclosure.
Get the Free 2026 Peptide Protocol Stack
Twelve compounds across four pillars: metabolic, tissue repair, longevity, cognitive. Citations included, formatted to print. Sent straight to your inbox.